Current evidence suggests that proinsulin contributes to the excess incidence of cardiovascular disease in T2DM by stimulating plasminogen activator inhibitor-1 secretion and the consecutive inhibition of fibrinolysis[27]. This evidence concerns the gene INS and type 2 diabetes mellitus.